EXCITE International and Izotropic Corporation are pleased to announce a partnership. With this EXCITE partnership, Izotropic will engage with EXCITE’s global network to align the device, clinical trial design, and regulatory strategy with potential payor groups, methodologists, and expert end-users.
The aim is to integrate all of the inputs from various groups to increase potential breadth and speed of adoption upon regulatory approval.
The expectation is for this work to be completed before the end of the calendar year.